126
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Profiles of gyrA Mutations and Plasmid-Mediated Quinolone Resistance Genes in Shigella Isolates with Different Levels of Fluoroquinolone Susceptibility

ORCID Icon, & ORCID Icon
Pages 2285-2290 | Published online: 12 Jul 2020

References

  • Xia S, Xu B, Huang L, et al. Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. J Clin Microbiol. 2011;49(1):232–242. doi:10.1128/JCM.01508-1021068291
  • von Seidlein L, Kim DR, Ali M, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 2006;3(9):e353. doi:10.1371/journal.pmed.003035316968124
  • Andersson MI, MacGowan AP. Development of the quinolones. J Antimicrob Chemother. 2003;51(Suppl 1):1–11. doi:10.1093/jac/dkg212
  • Fabrega A, Madurga S, Giralt E, Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol. 2009;2(1):40–61. doi:10.1111/j.1751-7915.2008.00063.x21261881
  • Pu XY, Zhang Q, Pan JC, Shen Z, Zhang W. Spontaneous mutation frequency and molecular mechanisms of Shigella flexneri fluoroquinolone resistance under antibiotic selective stress. World J Microbiol Biotechnol. 2013;29(2):365–371. doi:10.1007/s11274-012-1190-323070800
  • Giraud E, Baucheron S, Cloeckaert A. Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect. 2006;8(7):1937–1944. doi:10.1016/j.micinf.2005.12.02516714137
  • Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents. 2005;25(5):358–373. doi:10.1016/j.ijantimicag.2005.02.00615848289
  • Zhu J, Duan G, Yang H, Fan Q, Xi Y. Multi-drug resistance and characteristic of integrons in Shigella spp. isolated from China. Biomed Environ Sci. 2011;24(1):56–61. doi:10.3967/0895-3988.2011.01.00721440840
  • Chang Z, Zhang J, Ran L, et al. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004–2014. BMC Infect Dis. 2016;16(1):685. doi:10.1186/s12879-016-1977-127863468
  • World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Available from: http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Accessed 72, 2020.
  • Yang H, Duan G, Zhu J, Zhang W, Xi Y, Fan Q. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008. Int J Antimicrob Agents. 2013;42(2):173–177. doi:10.1016/j.ijantimicag.2013.04.02623796894
  • Gu B, Qin TT, Fan WT, et al. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002–2011. Int J Infect Dis. 2017;59:44–49. doi:10.1016/j.ijid.2017.03.02328392317
  • Qin T, Qian H, Fan W, et al. Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China. Antimicrob Resist Infect Control. 2017;6:97. doi:10.1186/s13756-017-0249-128932390
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI document M100 Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
  • CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests. 13th ed. CLSI document M02 Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Eaves DJ, Randall L, Gray DT, et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother. 2004;48(10):4012–4015. doi:10.1128/AAC.48.10.4012-4015.200415388468
  • Le TM, Baker S, Le TP, et al. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol. 2009;58(Pt 12):1585–1592. doi:10.1099/jmm.0.010033-019696153
  • Zhang W, Luo Y, Li J, et al. Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother. 2011;66(11):2527–2535. doi:10.1093/jac/dkr34121859815
  • Azmi IJ, Khajanchi BK, Akter F, et al. Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh. PLoS One. 2014;9(7):e102533. doi:10.1371/journal.pone.010253325028972
  • Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J Antimicrob Chemother. 2009;63(5):917–920. doi:10.1093/jac/dkp08719297378
  • Song Q, Lin W, Gao H, Yang Y, Xu J, Xu G. Changing antimicrobial resistance patterns and trends of Shigella isolates in Ningbo, Mid-East China, 2005–2013. Int J Antimicrob Agents. 2015;45(5):559–560. doi:10.1016/j.ijantimicag.2015.02.00125802232